#medvi

[ follow ]
#ai #telehealth #legal-issues #marketing-ethics #drug-marketing #ai-ethics #fda-violations #pharmaceuticals
#ai
fromFuturism
2 weeks ago
NYC startup

New York Times Makes Substantial Changes to Article That Glazed a Sleazy AI Startup: "Our Piece Should Have Included That Information"

Medvi, an AI-driven startup, faces legal scrutiny and regulatory violations despite being portrayed as a success story by the New York Times.
fromFuturism
3 weeks ago
Artificial intelligence

Why Is the New York Times Laundering the Reputation of a Sleazy AI Startup That's Selling GLP-1s via a Dishonest Dumpster Fire of Fake Doctors, Phony Before-and-After Pictures, a Warning From the FDA, and Other Glaring Red Flags?

Medvi, an AI-driven pharmaceutical company, is reportedly on track for $2 billion in sales with minimal human staff, raising concerns about its legitimacy.
NYC startup
fromFuturism
2 weeks ago

New York Times Makes Substantial Changes to Article That Glazed a Sleazy AI Startup: "Our Piece Should Have Included That Information"

Medvi, an AI-driven startup, faces legal scrutiny and regulatory violations despite being portrayed as a success story by the New York Times.
Artificial intelligence
fromFuturism
3 weeks ago

Why Is the New York Times Laundering the Reputation of a Sleazy AI Startup That's Selling GLP-1s via a Dishonest Dumpster Fire of Fake Doctors, Phony Before-and-After Pictures, a Warning From the FDA, and Other Glaring Red Flags?

Medvi, an AI-driven pharmaceutical company, is reportedly on track for $2 billion in sales with minimal human staff, raising concerns about its legitimacy.
more#ai
NYC startup
fromFuturism
2 weeks ago

AI-Powered Drug Marketer Medvi Responds After Allegations About Fake Doctors and Patients

Medvi, a drug marketing company, faces backlash for unethical practices despite a New York Times profile praising its AI-driven business model.
[ Load more ]